venBio Global Strategic Fund III, L.P. 13D/13G Filings for Artiva Biotherapeutics, Inc. (ARTV)

venBio Global Strategic Fund III, L.P. 13D and 13G filings for Artiva Biotherapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-15
4:44 pm
Sale
2025-03-3113GArtiva Biotherapeutics, Inc.
ARTV
venBio Global Strategic Fund III, L.P.1,198,975
4.900%
-320,996decrease
(-21.12%)
Filing
2024-11-14
4:56 pm
Sale
2024-09-3013GArtiva Biotherapeutics, Inc.
ARTV
venBio Global Strategic Fund III, L.P.1,519,971
6.300%
-298,624decrease
(-16.42%)
Filing
2024-08-01
7:00 pm
Purchase
2024-07-2213GArtiva Biotherapeutics, Inc.
ARTV
venBio Global Strategic Fund III, L.P.1,818,595
7.800%
1,818,595increase
(New Position)
Filing